Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 7th Avenue South
Institute for Cancer Outcomes and Survivorship
Birmingham, AL 35223
Summary
- Dr. Grant Williams is an Oncologist specializing in Gastrointestinal Cancer, based in Birmingham, AL. He completed his education and fellowships at the University of North Carolina Hospitals and Drexel University College of Medicine, his expertise lie in managing conditions such as breast cancer, lung cancer, and gastrointestinal malignancies particularly in older and vulnerable populations. Dr. Williams's research work has been published in prominent journals like the Journal of Clinical Oncology and the Lancet. He has also led multicenter clinical trials focused on examining body composition abnormalities such as sarcopenia and myosteatosis in older adults with colorectal cancer.
Education & Training
- University of Alabama at Birmingham School of Public HealthMSPH, Epidemiology, 2017 - 2019
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of North Carolina HospitalsFellowship, Geriatric Medicine (Internal Medicine), 2011 - 2012
- University of North Carolina HospitalsResidency, Internal Medicine, 2009 - 2011
- Drexel University College of MedicineClass of 2009
Certifications & Licensure
- AL State Medical License 2016 - 2025
- NC State Medical License 2009 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer Start of enrollment: 2014 Jun 01
- The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies.Smith Giri, Christian Harmon, Daniel Hess, Elizabeth M Cespedes Feliciano, Ijeamaka Anyene Fumagalli
Journal of Cachexia, Sarcopenia and Muscle. 2025-02-01 - Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.Howard J Lee Jr, John Boscardin, Louise C Walter, Alexander K Smith, Harvey J Cohen
The Oncologist. 2024-12-09 - "Start low, go slow," a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis.Gabriel Aleixo, Tej Patel, Julianne Ani, Will J Ferrell, Efrat Dotan
Journal of Geriatric Oncology. 2024-11-13
Press Mentions
- Why Are Black Cancer Patients Frailer Than Their Peers?June 17th, 2024
- Black Older Adults with Cancer More Likely to Be Frail, Have Functional ImpairmentsApril 11th, 2022
- Use Geriatric Assessment to Predict Hospital and Long-Term Care UtilizationApril 8th, 2019
- Join now to see all
Grant Support
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M StudyNational Cancer Institute2018–2023
- Paul Calabresi Career Development Award for Clinical Oncology (K12)National Cancer Institute2015–2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: